ID: ALA4758767

Max Phase: Preclinical

Molecular Formula: C46H57N11O10

Molecular Weight: 924.03

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(N)=O

Standard InChI:  InChI=1S/C46H57N11O10/c47-18-6-5-11-35(43(64)56-36(19-25-12-14-28(58)15-13-25)44(65)53-34(41(50)62)16-17-40(60)61)54-45(66)38(21-27-24-52-33-10-4-2-8-30(27)33)57-46(67)37(55-42(63)31(48)22-39(49)59)20-26-23-51-32-9-3-1-7-29(26)32/h1-4,7-10,12-15,23-24,31,34-38,51-52,58H,5-6,11,16-22,47-48H2,(H2,49,59)(H2,50,62)(H,53,65)(H,54,66)(H,55,63)(H,56,64)(H,57,67)(H,60,61)/t31-,34-,35-,36-,37-,38-/m0/s1

Standard InChI Key:  FSIFXQDHUWTUKW-DLXWRWKMSA-N

Associated Targets(Human)

Urotensin II receptor 1388 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 924.03Molecular Weight (Monoisotopic): 923.4290AlogP: -0.51#Rotatable Bonds: 26
Polar Surface Area: 372.83Molecular Species: ZWITTERIONHBA: 11HBD: 13
#RO5 Violations: 3HBA (Lipinski): 21HBD (Lipinski): 17#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.97CX Basic pKa: 10.27CX LogP: -3.46CX LogD: -3.56
Aromatic Rings: 5Heavy Atoms: 67QED Weighted: 0.03Np Likeness Score: 0.23

References

1. Bandholtz S,Erdmann S,von Hacht JL,Exner S,Krause G,Kleinau G,Grötzinger C.  (2016)  Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist.,  59  (22.0): [PMID:27791374] [10.1021/acs.jmedchem.6b00164]

Source